NASDAQ:RENE Cartesian Growth Co. II (RENE) Stock Price, News & Analysis $11.75 0.00 (0.00%) As of 05/13/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Cartesian Growth Co. II Stock (NASDAQ:RENE) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get RENE alerts:Sign Up Key Stats Today's Range$11.75▼$11.7550-Day Range$11.68▼$11.9752-Week Range$11.22▼$11.95Volume1 shsAverage Volume89,787 shsMarket Capitalization$254.05 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewCartesian Growth Corp. II operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on October 13, 2021 and is headquartered in New York, NY.Read More… Receive RENE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cartesian Growth Co. II and its competitors with MarketBeat's FREE daily newsletter. Email Address RENE Stock News HeadlinesCartesian Growth Corp II extends business combination periodMarch 5, 2025 | investing.comCartesian Growth Corp II extends business combination deadlineFebruary 5, 2025 | msn.comAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.May 22, 2025 | Paradigm Press (Ad)Positive Buy Rating for Cartesian Therapeutics Amid Encouraging Developments in Descartes-08 TrialsJanuary 28, 2025 | markets.businessinsider.comCartesian Growth Corporation IIDecember 23, 2024 | investing.comBertrand P. Grabowski's Net WorthNovember 2, 2024 | benzinga.comSee More Headlines RENE Stock Analysis - Frequently Asked Questions How have RENE shares performed this year? Cartesian Growth Co. II's stock was trading at $11.66 at the beginning of 2025. Since then, RENE stock has increased by 0.8% and is now trading at $11.75. View the best growth stocks for 2025 here. Who are Cartesian Growth Co. II's major shareholders? Cartesian Growth Co. II's top institutional shareholders include Mizuho Securities USA LLC (5.32%), Wolverine Asset Management LLC (1.18%) and Westchester Capital Management LLC (0.51%). How do I buy shares of Cartesian Growth Co. II? Shares of RENE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Cartesian Growth Co. II own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cartesian Growth Co. II investors own include AutoZone (AZO), Intel (INTC), TJX Companies (TJX), Abacus Health Products (ABAHF), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM) and Bank of America (BAC). Company Calendar Today5/22/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorFinancial Services Industry Holding & other investment offices Sub-IndustryTrading Current SymbolNASDAQ:RENE CIK1889112 Webwww.cartesiangrowth.com Phone212-461-6363FaxN/AEmployees2Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$11.44 million Net MarginsN/A Pretax MarginN/A Return on Equity-51.08% Return on Assets5.43% Debt Debt-to-Equity RatioN/A Current Ratio0.09 Quick Ratio0.09 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash Flow$0.40 per share Price / Cash Flow29.45 Book Value($0.64) per share Price / Book-18.36Miscellaneous Outstanding Shares21,621,000Free Float15,870,000Market Cap$254.05 million OptionableNot Optionable Beta-0.01 The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NASDAQ:RENE) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredWashington Is Broke—and Eyeing Your Savings NextWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cartesian Growth Co. II Please log in to your account or sign up in order to add this asset to your watchlist. Share Cartesian Growth Co. II With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.